However, its role as a modifier of cancer risk is controversial, as large case control studies by the Breast Cancer Association Consortium found no significant association with breast cancer risk [25] or breast cancer risk in BRCA1/BRCA2 mutation carriers [26]. This evidence concerns the gene BRCA2 and cancer.